Prokaryotic Expression Systems Market – Global Industry Analysis and Forecast (2022-2029)

Prokaryotic Expression Systems Market size was valued at US$ 294.74 Mn. in 2021 and is expected to reach US$ 811.73 Mn. by 2029 at a CAGR of 13.5% during the forecast period.
Prokaryotic Expression Systems Market Overview:
The most widely used system for protein large production for both industry and laboratory is called a prokaryotic system. Bacteria assist as a rapid and simple system of expressing recombinant protein due to short doubling time. The cost of culture is relatively low and is affordable for large-scale production for industrial applications.

To know about the Research Methodology :- Request Free Sample Report
Prokaryotic Expression Systems Market Dynamics:
Prokaryotic Expression Systems are likely to grow at a high pace in the forecast period due to rising awareness among individuals in concern with the benefits offered by the prokaryotic expression system. As prokaryotic system allows to obtain large-scale production of recombinant protein in a short time.

Growing demand for protein application in therapeutics for human treatment, biologics market, abundant and easy availability of host bacteria, surging geriatric population together with growing chronic disease is likely to lift the growth of the market in the forecast period. Further, growing treatment options across the world are likely to fuel the growth of the market in the coming future. In addition, Genomics is likely to drive the growth of the market due to genomic sequencing together with researchers working on technologies boost the market of proteomics is particularly important owing to most diseases are manifested at the level of protein activity.

New entrants with a wide range of supplementing products with the high cost of protein expression reagent are likely to act as a restraining factor to the market. Further, in the prokaryotic expression system, the protein expression market has gained the highest revenue in 2021. This is further followed by the eukaryotic expression system, and this system is likely to grow with a CAGR of 9.4% in the forecast period.
Prokaryotic Expression Systems Market Segment Analysis:
Amino Acid Product Type Segment is dominating the Prokaryotic Expression Systems Market:

The amino acid segment is dominating the prokaryotic expression system market. The global amino acid market was valued at 20.38 billion in 2021 and is projected to grow with a CAGR of 7.5% in the forecast period. The growth of the Amino acid segment is attributed to increasing demand for food products with an amino acid content, growing pharmaceutical industry, and demand for nutraceutical industry is likely to hit the growth of the market in the forecast period.

The growth of the market players with expansion in a production facility is likely to fuel the market growth. For instance, Ajinomoto Co., Inc., is a leading market player of Amino Acid and anticipated to boost their production facility in Brazil to supply products due to the rise in the personal care industry. Moreover, the food and dietary supplement is a major application of amino acids is and is anticipated to boost the market of amino acids.

The Escherichia coli system segment is considered to supplement the growth of the Prokaryotic Expression Systems Market:

Escherichia coli is the dominating host type segment of the prokaryotic expression system market. The growth of the market is driven by the large-scale production of a protein with the help of E. coli bacteria as E. coli is the most used artificial expression host. E. coli is widely used due to its genomic and physiological sequencing system that is responsible to simplify the cloning procedure and this factor is responsible to make the E. coli host most popular in the pharmaceutical industry. Further, this process is responsible to increase the binding strength of promoter region 7 and helps in assisting the transcription process. Moreover, prokaryotic expression plays a vital role in the pharmaceutical and biotechnology industry. These factors are estimated to stimulate the growth of the market.

The Research Application segment is gaining more attention in the Prokaryotic Expression Systems Market:

The research Application segment is dominating the prokaryotic expression system market. The growth of the segment is attributed to the large-scale application of and benefits like prokaryotes are grown quickly, and are most quickly used in molecular biology, genetics, and biochemistry research. Prokaryotic are important to all living organisms present on earth and play a critical role in recycling nutrients by decomposing dead organisms. And due to this factor, they are widely used in research activity as healthy bacteria. Moreover, research studies are been conducted to improve the activity of prokaryotic in the pharmaceutical industry and biotechnology industry to enhance the action of pharmaceutical drugs.

Mounting the genetic toolbox for prokaryotic synthetic biology is a business strategy to improving the dynamics of gene expression and enabling engineered application of research and biomedicines. However, the current trend of moving genetic parts from prokaryotic to eukaryotic for the corresponding DNA-binding sequencing by E.coli is likely to boost the market growth.
Prokaryotic Expression Systems Market Regional Insights:
North America dominates the Prokaryotic Expression Systems market owing to increasing development strategies made by various industry verticals in the region and developing technologies to identify the biomarkers of disease. The increasing demand for genomic sequencing is likely to boost the growth of the market.

Moreover, Healthcare infrastructure and technological advancement are likely to motivate the growth of the market. As companies are improving the manufacturing standards in North America. Further mergers and acquisitions are playing an important role in North America to strengthen market growth and to sustain in the global market.

For Instance, in April 2021, US-based leading life science research organization, Bio-Rad laboratories, inc., acquired Celsee, Inc. to offers instruments and consumables for the isolation, detection, and analysis of single cells.

The Asia Pacific accounted for a reasonable share in the Prokaryotic Expression Systems market. Factors ascribing to the growth of the region are cumulative research studies carried out by the market players and growing investment in research and development activities gene expression is likely to motivate the market growth.

The objective of the report is to present a comprehensive analysis of the Global Prokaryotic Expression Systems Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Prokaryotic Expression Systems Market dynamics, structure by analyzing the market segments and project the Global Prokaryotic Expression Systems Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Type portfolio, growth strategies, and regional presence in the Global Prokaryotic Expression Systems Market make the report investor’s guide
Prokaryotic Expression Systems Market Scope: Inquire before buying



Global Prokaryotic Expression Systems Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2029


Historical Data:
2017 to 2021
Market Size in 2021:
US $ 294.74 Mn.


Forecast Period 2022 to 2029 CAGR:
13.5%
Market Size in 2029:
US $ 811.73 Mn.


 Segments Covered:
by Product Type
• Amino Acids
• Biopolymers
• Ascorbic Acids
• Pigments
• Enzymes
• Antibiotics
• Lipases


by Host Type
• Archaea
• Bacillus Subtilis
• Corynebacterium Glutamicum
• Escherichia Coli Systems
• Pseudomonas Alcaligenes


by End-User
• Academic Research
• Biotechnological Companies
• Pharmaceuticals
• Contract Research Organizations


by Application
• Research Applications
• Therapeutic Proteins
• Industrial Proteins


by Material
• Reagents
• Expression vectors
• Competent cells
• Instruments
• Services



Prokaryotic Expression Systems Market, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Prokaryotic Expression Systems Market Key Players
• Agilent Technologies, Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• QIAGEN
• Promega Corporation.
• Thermo Fischer Scientific, Inc.
• Life Technologies Corporation.
• Takara Bio Inc.
• GenScript, Lonza.
• New England Biolabs.
• OXFORD EXPRESSION TECHNOLOGIES LTD
• LifeSensors, Proteogenix
• Synthetic Genomics Inc.
• Peak Proteins Ltd
• ProMab, Sino Biological Inc.
• Lucigen
• ARTES Biotechnology GmbH
• Jena Bioscience GmbH
• BIONEER CORPORATION
• LenioBio.
FAQs:
1. What is the global Prokaryotic Expression Systems market share in 2021?

Ans: Approximately, 294.74 Million USD.

2. Which application segment is dominating the Prokaryotic Expression Systems market?

Ans: The research application are the main applications for Prokaryotic Expression Systems across the globe due to the translational studies in the genomic sector helps the researchers to analyses the behavior of human tissue and cells from different human beings in different climate and environment

3. Which Prokaryotic Expression Systems product is expected to dominate the market during the forecast period?

Ans: Amino Acid segment is considered to dominate the market as the Application segment is more cost-effective and resourceful and abundantly used in pharmaceutical applications as well as for biotechnology industries.

4. Which region is expected to dominate the Prokaryotic Expression Systems market during the forecast period?

Ans: North America dominates the Prokaryotic Expression Systems market owing to increasing development in healthcare facilities. Moreover, increasing demand for better technologies with improved additions is the key factor considered to drive the growth of the Prokaryotic Expression Systems market.

5. What are the key players of the Prokaryotic Expression System market?

Ans: Following are the key players responsible for the growth of the market Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., QIAGEN, Promega Corporation., Thermo Fischer Scientific, Inc., Life Technologies Corporation., Takara Bio Inc., GenScript, Lonza.,.